FY2027-Q1 revenue was ¥10,376 million, operating profit was ¥2,971 million, and profit attributable to owners of the parent was ¥2,057 million, representing strong progress against the full-year forecast. However, because hiring in April, including nurse placements, creates a first-quarter bias, FY2027-H1 should clarify whether the strong progress reflects seasonality alone or indicates upside potential to the full-year plan.
All recorded disclosures and news since the latest annual or semiannual filing. Switching watchpoints keeps the full history. Select an item to inspect its source.2026-06-19 〜 2026-10-26 · 29 of 29 items
Scroll the timeline →
Revenue was ¥10,376 million, with progress of 29.8% against the ¥34,800 million full-year forecast. Can this pace be maintained?
Operating profit was ¥2,971 million, or 72.3% of the ¥4,110 million full-year forecast. Will the ¥1,139 million still required after Q1 remain within reach?
Net profit was ¥2,057 million, or 73.3% of the ¥2,805 million full-year forecast. The remaining ¥748 million required should be monitored.
Will the company disclose year-on-year changes in operating profit and net profit for FY2027-H1, and whether it has revised its full-year forecasts?
The company's ongoing themes and initiatives this watchpoint touches on.
FY2027-Q1 revenue was ¥10,376 million, up 5.2% year on year, operating profit was ¥2,971 million, up 4.6%, ordinary profit was ¥2,992 million, up 4.9%, and profit attributable to owners of the parent was ¥2,057 million, up 9.4%. Operating profit growth was slightly below revenue growth, while net profit was relatively strong, increasing 9.4% year on year. The equity ratio also improved by 1.8 percentage points, from 74.7% at the end of the previous fiscal year to 76.5%.
The FY2027 full-year forecasts are revenue of ¥34,800 million, operating profit of ¥4,110 million, ordinary profit of ¥4,220 million, and net profit of ¥2,805 million. Comparing Q1 results mechanically with the full-year forecasts gives progress rates of 29.8% for revenue, 72.3% for operating profit, and 73.3% for net profit. At the end of Q1, only ¥1,139 million of operating profit and ¥748 million of net profit remained to reach the full-year forecasts, making apparent progress against the plan high.
However, the company has consistently disclosed seasonality in which profit is weighted toward the first quarter, because the proportion of April hires is high in the nursing sector and revenue from recruitment services is concentrated at the beginning of the fiscal year. Accordingly, it is difficult to view the 72.3% progress rate for Q1 operating profit as a direct signal of upside to the full-year forecast. In FY2027-H1, it will be necessary to determine, alongside year-on-year comparisons, whether Q1’s high profitability continued into Q2 or whether profit slowed sharply in Q2 alone.
In its Q1 disclosure, the company left its previous consolidated full-year forecasts unchanged, but did not provide progress rates against those forecasts or the segment-level profit amounts required from Q2 onward. In the next results announcement, we will want to confirm not only cumulative operating profit, but also how much each segment, including Human Resources Services, Recruiting, Regional Information Services, the HR Platform, and Overseas Operations, is expected to contribute toward achieving the full-year plan, as well as the basis for leaving the full-year forecasts unchanged.
Operating profit (¥ million; full-year forecast: 4,110)
Select a value or step to inspect its source.
Ordered by date. Disclosures and financial records differ from news and company threads; open each source to inspect it.
2026-10-30 · Awaiting publication
· Awaiting publication
The prior-year comparison for this event
2025-10-31 disclosed · In ¥ millions; each quarter is cumulative from the start of the fiscal year. EPS is in yen.
Latest available: FY2027 Q1
Net salesBusiness scale
17,972JPY m
↗ +4.8% YoYOperating profitCore earnings
3,863JPY m
↗ +2.1% YoYNewest first. The highlighted column is this event’s comparison. YoY uses the same period and accounting basis.
| Metric | FY2027 Q1 | FY2026 full year | FY2026 Q3 | FY2026 Q2Comparison | FY2026 Q1 | FY2025 full year | FY2025 Q3 | FY2025 Q2 |
|---|---|---|---|---|---|---|---|---|
| Net sales | 10,376↗ +5.2% YoY | 33,924↗ +4.4% YoY | 25,383↗ +5.0% YoY | 17,972↗ +4.8% YoY | 9,863YoY unavailable | 32,501YoY unavailable | 24,183YoY unavailable | 17,145YoY unavailable |
| Operating profit | 2,971↗ +4.6% YoY | 4,583↗ +1.1% YoY | 4,212↗ +2.4% YoY | 3,863↗ +2.1% YoY | 2,840YoY unavailable | 4,533YoY unavailable | 4,113YoY unavailable | 3,783YoY unavailable |
| Ordinary profit | 2,992↗ +4.9% YoY | 4,689↗ +1.7% YoY | 4,276↗ +2.5% YoY | 3,901↗ +2.2% YoY | 2,852YoY unavailable | 4,611YoY unavailable | 4,170YoY unavailable | 3,817YoY unavailable |
| Net income | 2,057↗ +9.4% YoY | 4,158↗ +16.0% YoY | 3,673↗ +9.9% YoY | 2,598↘ -16.6% YoY | 1,880YoY unavailable | 3,583YoY unavailable | 3,341YoY unavailable | 3,114YoY unavailable |
| Earnings per share | 36.77↘ -63.4% YoY | 74.11↘ -61.3% YoY | 65.45↘ -63.4% YoY | 138.92↘ -16.6% YoY | 100.51YoY unavailable | 191.56YoY unavailable | 178.62YoY unavailable | 166.49YoY unavailable |